While the world keeps getting better at churning semiconductors, we are still struggling to find new drugs to treat resistant diseases, and the process isn't getting cheaper. "Today, drug development still takes on average 10-15 years of R&D with a cost of production (around $2.5 billion) that has increased dramatically over the last decade despite improvements in technology: this is the concept of Eroom's law (Moore’s law spelled backwards)," deep tech VC Florian Denis wrote in a recent Medium post. While AI could help uncover new drugs, "the AI analysis is really only as good as the data that you put into it," Pepper Bio CEO Jon Hu told me.
The biotech startup's $6.5 million seed round is led by VC firm NFX but it is perhaps equally noteworthy to see that Merck is also participating in the round.
NFX & Merck Back Pepper Bio, the Google Maps for Drug Discovery, with $6 5M to Streamline R&D webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.
While the world keeps getting better at churning semiconductors, we are still struggling to find new drugs to treat resistant diseases, and the process isn't getting cheaper. "Today, drug development still takes on average 10-15 years of R&D with a cost of production (around $2.5 billion) that has increased dramatically over the last decade despite improvements in technology: this is the concept of Eroom's law (Moore’s law spelled backwards)," deep tech VC Florian Denis wrote in a recent Medium post. While AI could help uncover new drugs, "the AI analysis is really only as good as the data that you put into it," Pepper Bio CEO Jon Hu told me.